serw-MX  [xml]  
 


    
 DeCS Categories

C05 Musculoskeletal Diseases .
C05.116 Bone Diseases .
C05.116.198 Bone Diseases, Metabolic .
C05.116.198.371 Mucolipidoses .
C05.360 Foot Diseases .
C05.360.500 Metatarsalgia .
C05.360.500.500 Morton Neuroma .
C05.550 Joint Diseases .
C05.550.610 Metatarsalgia .
C05.550.610.500 Morton Neuroma .
C09 Otorhinolaryngologic Diseases .
C09.218 Ear Diseases .
C09.218.568 Labyrinth Diseases .
C09.218.568.217 Endolymphatic Hydrops .
C09.218.568.217.500 Meniere Disease .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.163 Brain Diseases, Metabolic .
C10.228.140.163.100 Brain Diseases, Metabolic, Inborn .
C10.228.140.163.100.435 Lysosomal Storage Diseases, Nervous System .
C10.228.140.163.100.435.590 Mucolipidoses .
C10.292 Cranial Nerve Diseases .
C10.292.650 Olfactory Nerve Diseases .
C10.668 Neuromuscular Diseases .
C10.668.829 Peripheral Nervous System Diseases .
C10.668.829.600 Neuralgia .
C10.668.829.600.375 Morton Neuroma .
C16 Congenital, Hereditary, and Neonatal Diseases and Abnormalities .
C16.320 Genetic Diseases, Inborn .
C16.320.565 Metabolism, Inborn Errors .
C16.320.565.189 Brain Diseases, Metabolic, Inborn .
C16.320.565.189.435 Lysosomal Storage Diseases, Nervous System .
C16.320.565.189.435.590 Mucolipidoses .
C16.320.565.202 Carbohydrate Metabolism, Inborn Errors .
C16.320.565.202.670 Mucolipidoses .
C16.320.565.595 Lysosomal Storage Diseases .
C16.320.565.595.554 Lysosomal Storage Diseases, Nervous System .
C16.320.565.595.554.590 Mucolipidoses .
C18 Nutritional and Metabolic Diseases .
C18.452 Metabolic Diseases .
C18.452.132 Brain Diseases, Metabolic .
C18.452.132.100 Brain Diseases, Metabolic, Inborn .
C18.452.132.100.435 Lysosomal Storage Diseases, Nervous System .
C18.452.132.100.435.590 Mucolipidoses .
C18.452.648 Metabolism, Inborn Errors .
C18.452.648.189 Brain Diseases, Metabolic, Inborn .
C18.452.648.189.435 Lysosomal Storage Diseases, Nervous System .
C18.452.648.189.435.590 Mucolipidoses .
C18.452.648.202 Carbohydrate Metabolism, Inborn Errors .
C18.452.648.202.670 Mucolipidoses .
C18.452.648.595 Lysosomal Storage Diseases .
C18.452.648.595.554 Lysosomal Storage Diseases, Nervous System .
C18.452.648.595.554.590 Mucolipidoses .
C23 Pathological Conditions, Signs and Symptoms .
C23.550 Pathologic Processes .
C23.550.288 Disease .
C23.888 Signs and Symptoms .
C23.888.592 Neurologic Manifestations .
C23.888.592.612 Pain 7776 .
C23.888.592.612.540 Metatarsalgia .
C23.888.592.612.540.500 Morton Neuroma .
C23.888.592.612.664 Neuralgia .
C23.888.592.612.664.275 Morton Neuroma .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.503 Lectins .
D12.776.503.140 Discoidins .
D12.776.820 Protozoan Proteins .
D12.776.820.250 Discoidins .
HP1 Homeopathy .
HP1.007 Homeopathic Philosophy .
HP1.007.262 Patients .
HP1.007.262.808 Disease .
HP2 Homeopathic Clinics .
HP2.029 Disease .
SH1 Health Sciences, Technology and Innovation Management .
SH1.010 Policies and Cooperation in Science, Technology and Innovation .
SH1.010.020 International Cooperation .
SH1.010.020.060 Science and Technology Information Networks .
SH1.010.020.060.030 International Research Information System .
SP5 Epidemiology and Biostatistics .
SP5.001 Epidemiology .
SP5.001.002 Health-Disease Process .
SP5.001.002.013 Disease .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Mucolipidoses .
Cherry Red Spot-Myoclonus Syndrome .
Deficiency Disease, Ganglioside Sialidase .
Glycoprotein Neuraminidase Deficiency .
Inclusion Cell Disease .
Mucolipidosis I .
Mucolipidosis II .
Mucolipidosis III .
Mucolipidosis III Alpha Beta .
Mucolipidosis IIIa .
Mucolipidosis IV .
Mucolipidosis Type 1 .
Mucolipidosis Type I .
Mucolipidosis Type II .
Mucolipidosis Type III .
Mucolipidosis Type IV .
Myoclonus-Cherry Red Spot Syndrome .
Psuedo-Hurler Disease .
Sialolipidosis .
Type I Mucolipidosis .
Type II Mucolipidosis .
Type III Mucolipidosis .
Type IV Mucolipidosis .
Deficiencies, Glycoprotein Neuraminidase .
Deficiency, Glycoprotein Neuraminidase .
Glycoprotein Neuraminidase Deficiencies .
I Cell Disease .
I-Cell Diseases .
Inclusion Cell Diseases .
Lipomucopolysaccharidoses .
Mucolipidoses, Type I .
Mucolipidoses, Type II .
Mucolipidoses, Type III .
Mucolipidoses, Type IV .
Mucolipidosis, Type I .
Mucolipidosis, Type II .
Mucolipidosis, Type III .
Mucolipidosis, Type IV .
Polydystrophy, Pseudo-Hurler .
Pseudo Hurler Polydystrophy .
Psuedo Hurler Disease .
Psuedo-Hurler Diseases .
Sialidoses .
Sialolipidoses .
Type I Mucolipidoses .
Type II Mucolipidoses .
Type III Mucolipidoses .
Type IV Mucolipidoses .
I-Cell Disease .
Lipomucopolysaccharidosis .
Pseudo-Hurler Polydystrophy .
Cherry Red Spot Myoclonus Syndrome .
Ganglioside Sialidase Deficiency Disease .
Mucolipidosis .
Myoclonus Cherry Red Spot Syndrome .
Sialidosis .
A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7) .
0.48
11967
 
Olfactory Nerve Diseases .
Cranial Nerve I Disorders .
Olfactory Nerve Disease .
Cranial Nerve I Diseases .
First Cranial Nerve Diseases .
Diseases of the first cranial (olfactory) nerve, which usually feature anosmia or other alterations in the sense of smell and taste. Anosmia may be associated with NEOPLASMS; CENTRAL NERVOUS SYSTEM INFECTIONS; CRANIOCEREBRAL TRAUMA; inherited conditions; toxins; METABOLIC DISEASES; tobacco abuse; and other conditions. (Adams et al., Principles of Neurology, 6th ed, pp229-31) .
0.42
534
 
Meniere Disease .
Auditory Vertigo .
Aural Vertigo .
Ménière Disease .
Ménière's Disease .
Ménière's Vertigo .
Otogenic Vertigo .
Auditory Vertigos .
Disease, Meniere .
Disease, Meniere's .
Disease, Ménière .
Disease, Ménière's .
Diseases, Ménière .
Diseases, Ménière's .
Meniere Syndrome .
Menieres Disease .
Menieres Syndrome .
Ménière Diseases .
Ménière Vertigo .
Ménière's Diseases .
Ménière's Vertigos .
Ménières Disease .
Ménières Vertigo .
Otogenic Vertigos .
Syndrome, Meniere's .
Vertigo, Auditory .
Vertigo, Ménière's .
Vertigo, Otogenic .
Vertigos, Auditory .
Vertigos, Ménière's .
Vertigos, Otogenic .
Meniere's Disease .
Vertigo, Aural .
Meniere's Syndrome .
Meniere's Disease n .
A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural fullness. It is the most common form of endolymphatic hydrops. .
0.38
1235739
 
Disease .
Diseases .
Illness .
Disease Concept Evolution .
A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown. .
0.37
99017203
 
Discoidins .
Discoidin-I .
Discoidin-II .
Discoidin I .
Discoidin II .
Lectins that were identified in DICTYOSTELIUM DISCOIDEUM. They bind to GALACTOSE and are involved in cell-substratum adhesion, maintenance of morphology during aggregation, and spore formation. .
0.37
0126
 
Morton Neuroma .
Intermetatarsal Neuroma .
Morton's Disease .
Morton's Metatarsalgia .
Morton's Neuralgia .
Morton's Neuroma .
Disease, Morton's .
Intermetatarsal Neuromas .
Metatarsalgia, Morton's .
Morton Disease .
Morton Metatarsalgia .
Morton Neuralgia .
Mortons Disease .
Mortons Metatarsalgia .
Mortons Neuralgia .
Mortons Neuroma .
Neuralgia, Morton's .
Neuroma, Intermetatarsal .
Neuroma, Morton .
Neuroma, Morton's .
Neuromas, Intermetatarsal .
A nerve inflammation in the foot caused by chronic compression of the plantar nerve between the METATARSAL BONES. .
0.37
022
 
International Research Information System .
I-Research .
Global Information System for National Research Councils, established by the National Research Council of the Netherlands, with the aim of forming an international network of national research institutes to share information about research and researchers from each participating country. (Free translation from the original: http://www.nwo.nl/nwohome.nsf/pages/NWOP_5VLHS2_Eng) .
0.37
00